Yoshiki Terada

841 total citations
42 papers, 573 citations indexed

About

Yoshiki Terada is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Yoshiki Terada has authored 42 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 10 papers in Oncology and 9 papers in Immunology. Recurrent topics in Yoshiki Terada's work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (5 papers) and Immune Cell Function and Interaction (5 papers). Yoshiki Terada is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (5 papers) and Immune Cell Function and Interaction (5 papers). Yoshiki Terada collaborates with scholars based in Japan. Yoshiki Terada's co-authors include Hirohisa Nakamae, Masayuki Hino, Takahisa Yamane, Kensuke Ohta, Mika Nakamae, Takahiko Nakane, Kei Tsumura, Taro Hasegawa, Hideo Koh and Yoshitaka Nakao and has published in prestigious journals such as Blood, Cancer and Physiology & Behavior.

In The Last Decade

Yoshiki Terada

39 papers receiving 560 citations

Peers

Countries citing papers authored by Yoshiki Terada

Since Specialization

Citations

This map shows the geographic impact of Yoshiki Terada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshiki Terada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshiki Terada more than expected).

Fields of papers citing papers by Yoshiki Terada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshiki Terada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshiki Terada. The network helps show where Yoshiki Terada may publish in the future.

Co-authorship network of co-authors of Yoshiki Terada

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshiki Terada. A scholar is included among the top collaborators of Yoshiki Terada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshiki Terada. Yoshiki Terada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	[Angioimmunoblastic T cell lymphoma complicated with endocapillary proliferative glomerulonephritis]. 2013 ·PubMed ·(unknown), (unknown), (unknown), Eiji Ishimura, (unknown), (unknown), (unknown), Takuro Yoshimura, Mitsutaka Nishimoto, Yoshiki Hayashi, Yoshiki Terada, Takahiko Nakane, Hideo Koh, Yoshitaka Nakao, Masahiko Ohsawa, Masayuki Hino	1
2	Risk factors affecting cardiac left-ventricular hypertrophy and systolic and diastolic function in the chronic phase of allogeneic hematopoietic cell transplantation 2012 ·Bone Marrow Transplantation ·Mitsutaka Nishimoto, Hirohisa Nakamae, (unknown), Takahiko Nakane, Mika Nakamae, Asao Hirose, (unknown), Yoshitaka Nakao, Yoshiki Terada, Masahiko Ohsawa, Masayuki Hino	4
3	Fatal BK virus pneumonia following stem cell transplantation 2012 ·Transplant Infectious Disease ·(unknown), Yoshiki Terada, Takahisa Yamane, Shogo Tanaka, (unknown), (unknown), Takahiko Nakane, (unknown), Hirohisa Nakamae, Masahiko Ohsawa, K Wakasa, Masayuki Hino	22
4	Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib 2012 ·Leukemia & lymphoma ·Yoshiki Hayashi, Hirohisa Nakamae, (unknown), Takahiko Nakane, Hideo Koh, Mika Nakamae, Asao Hirose, (unknown), Yoshiki Terada, Yoshitaka Nakao, Masayuki Hino	46
5	Immunoglobulin Prophylaxis Against Cytomegalovirus Infection in Patients at High Risk of Infection Following Allogeneic Hematopoietic Cell Transplantation 2011 ·Transplantation Proceedings ·(unknown), Hirohisa Nakamae, Asao Hirose, Takahiko Nakane, (unknown), Yoshiki Hayashi, Mitsutaka Nishimoto, Mika Nakamae, Masahiro Yoshida, (unknown), Hiroshi Okamura, (unknown), Masahiro Manabe, (unknown), Yoshiki Terada, Yoshitaka Nakao, Masayuki Hino	8
6	Reduced-intensity conditioning by fludarabine/busulfan without additional irradiation or T-cell depletion leads to low non-relapse mortality in unrelated bone marrow transplantation 2011 ·International Journal of Hematology ·Takahiko Nakane, Hirohisa Nakamae, Hideo Koh, Mika Nakamae, Yoshiki Hayashi, Mitsutaka Nishimoto, Takuro Yoshimura, Eri Inoue, Atsushi Inoue, (unknown), (unknown), Yoshiki Terada, Ki‐Ryang Koh, Takahisa Yamane, Masayuki Hino	7
7	Serum Cytokine Profiles at the Onset of Severe, Diffuse Alveolar Hemorrhage Complicating Allogeneic Hematopoietic Stem Cell Transplantation, Treated Successfully with Pulse Intravenous Cyclophosphamide 2010 ·Acta Haematologica ·Hideo Koh, Hirohisa Nakamae, Ki‐Ryang Koh, Masahiko Ohsawa, Takahiko Nakane, (unknown), (unknown), (unknown), (unknown), Yoshiki Terada, Takahisa Yamane, Masayuki Hino	8
8	Heart rate variability during and after peripheral blood stem cell leukapheresis in autologous transplant patients and allogeneic transplant donors 2010 ·International Journal of Hematology ·Takahiko Nakane, Hirohisa Nakamae, Hideo Koh, Mika Nakamae, (unknown), Yoshiki Terada, Ki‐Ryang Koh, Takahisa Yamane, Masayuki Hino	2
9	Cardiac and autonomic nerve function after reduced-intensity stem cell transplantation for hematologic malignancy in patients with pre-transplant cardiac dysfunction 2009 ·Annals of Hematology ·Takahiko Nakane, Hirohisa Nakamae, Takashi Muro, Hiroyuki Yamagishi, Yoshiki Kobayashi, (unknown), Erina Sakamoto, Yoshiki Terada, Mika Nakamae, Ki‐Ryang Koh, Takahisa Yamane, Minoru Yoshiyama, Masayuki Hino	0
10	Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan 2009 ·International Journal of Hematology ·Kensuke Ohta, (unknown), Yoshitaka Nakao, (unknown), (unknown), Erina Sakamoto, Shuichiro Okamoto, Asao Hirose, Yasutaka Aoyama, (unknown), Yoshiki Hayashi, (unknown), Yoshiki Terada, (unknown), Takahiko Nakane, Hideo Koh, Masayuki Hino	6
11	Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma 2009 ·Journal of Experimental & Clinical Cancer Research ·Yoshiki Terada, Hirohisa Nakamae, (unknown), (unknown), Erina Sakamoto, (unknown), Eri Inoue, Hideo Koh, Takahiko Nakane, (unknown), Masahiko Ohsawa, Ki‐Ryang Koh, Takahisa Yamane, Yoshitaka Nakao, Kensuke Ohta, Atsuko Mugitani, Hirofumi Teshima, Masayuki Hino	49
12	Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation 2008 ·Bone Marrow Transplantation ·Takahiko Nakane, Hirohisa Nakamae, Hiroshi Kamoi, (unknown), (unknown), Erina Sakamoto, (unknown), Mika Nakamae, Kensuke Ohta, Yoshiki Terada, (unknown), Takahisa Yamane, Masayuki Hino	15
13	Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation 2006 ·American Journal of Hematology ·Hirohisa Nakamae, Takahisa Yamane, Taro Hasegawa, Mika Nakamae, Yoshiki Terada, (unknown), Kensuke Ohta, Masayuki Hino	77
14	Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone 2005 ·Cancer ·Hirohisa Nakamae, Kei Tsumura, Yoshiki Terada, Takahiko Nakane, Mika Nakamae, Kensuke Ohta, Takahisa Yamane, Masayuki Hino	178
15	Clinical Significance of Positive Clostridium Difficile (CD) Toxin in the Stool of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT). 2004 ·Blood ·Yoshiki Terada, Yasushi Onishi, Sung‐Won Kim, Masahiro Kami, Shin‐ichiro Mori, Yuji Heike, Yoichi Takaue, Ryuji Tanosaki	3
16	Thrombopoietin stimulates ex vivo expansion of mature neutrophils in the early stages of differentiation 2003 ·Annals of Hematology ·Yoshiki Terada, Fumihiko Hato, Chikahiko Sakamoto, Taro Hasegawa, Kenichi Suzuki, Hirohisa Nakamae, Kensuke Ohta, Takahisa Yamane, Seiichi Kitagawa, Masayuki Hino	4
17	Excretion of Granulocyte Colony-Stimulating Factor into Human Breast Milk 2003 ·Acta Haematologica ·(unknown), Takahisa Yamane, Yasutaka Aoyama, (unknown), Taro Hasegawa, Chikahiko Sakamoto, Yoshiki Terada, (unknown), Masayuki Hino	3
18	Primary refractoriness to platelet transfusion caused by Nak^a antibody alone 2001 ·Vox Sanguinis ·(unknown), Kensuke Ohta, (unknown), Nobuo Nagao, Masayuki Hino, Takahisa Yamane, (unknown), (unknown), Asao Hirose, Yasutaka Aoyama, Hirohisa Nakamae, Yoshiki Terada, T Takubo, N Tatsumi	12
19	Collaborative Behavioral Teratology Study of Phenytoin: A Test Battery for Neurobehavioral Developmental Toxicity in Rats. 1998 ·Congenital Anomalies ·(unknown), Yoshiki Terada, Toshiaki Tachibana, Takashi Tanimura	9
20	Estimated magnitude of behavioral effects of phenytoin in rats and its reproducibility: A collaborative behavioral teratology study in Japan 1996 ·Physiology & Behavior ·Toshiaki Tachibana, Yoshiki Terada, (unknown), Takashi Tanimura	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact